TY - JOUR
T1 - Whole-body vibration as antihypertensive non-pharmacological treatment in hypertensive individuals with knee osteoarthritis
T2 - Randomized cross-over trial
AU - Moreira-Marconi, Eloá
AU - Caiado, Vanessa da Silva
AU - Teixeira-Silva, Ygor
AU - de Meirelles, Alexandre Gonçalves
AU - Moura-Fernandes, Marcia Cristina
AU - Lopes-Souza, Patrícia
AU - Reis-Silva, Aline
AU - Sá-Caputo, Danúbia C.
AU - Paineiras-Domingos, Laisa L.
AU - Lacerda, Ana Cristina Rodrigues
AU - Mendonça, Vanessa Amaral
AU - Cordeiro, Ricardo Gonçalves
AU - Taiar, Redha
AU - Sartorio, Alessandro
AU - Wong, Alexei
AU - Sañudo, Borja
AU - Bernardo-Filho, Mario
N1 - Funding Information:
Funding: This research was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) (finance code 001), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), the Universidade do Estado do Rio de Janeiro (UERJ) and the Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ).
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - (1) Background: Hypertension is a serious medical condition characterized by a persistent increase in blood pressure (BP), which is prevalent in individuals with knee osteoarthritis (KOA). Pharmacological interventions are normally used to treat both hypertension and KOA; however, a more sustainable form of treatment is desirable for these clinical conditions. Whole-body vibration (WBV) exercise has been proposed as a non-pharmacological therapy for reducing both BP and KOA symptomatology. This study aimed to evaluate the antihypertensive effect of WBV in hypertensive individuals with KOA. (2) Methods: Nineteen hypertensive individuals with KOA were randomly allocated to either a control (CG) (n = 9) or a WBV group (WBVG) (n = 10). Subjects in the WBVG were positioned sitting in a chair in front of a vibrating platform (VP) with the feet on the base (peak-to-peak displacement 2.5, 5.0 and 7.5 mm; frequencies 5 to 14 Hz). In the CG, subjects assumed the same position with the VP turned off. The protocols in the CG and WBVG were performed 2 days/week for a total of 5 weeks. (3) Results: No baseline differences (age, anthropometrics, BP parameters and medications) between the groups were found (p > 0.05). WBV exercise reduced systolic BP (SBP: 126.1 ± 2.7 versus 119.1 ± 3.2 mmHg; p = 0.001; post hoc: p = 0.02; F = 23.97) and mean BP (MBP: 82.6 ± 1.8 versus 78.7 ± 1.8, p = 0.001, post hoc: p = 0.02; F = 23.97), while no significant changes were found in diastolic BP (DBP: 68.5 ± 2.2 versus 64.4 ± 2.3; p = 0.11; F = 2.68). (4) Conclusions: WBV might be considered a sustainable therapy for exerting an antihypertensive effect in medicated hypertensive individuals with KOA. This decline in BP might translate to a reduction in pharmacological need, although further studies are necessary to understand the mechanisms underlying the described effect.
AB - (1) Background: Hypertension is a serious medical condition characterized by a persistent increase in blood pressure (BP), which is prevalent in individuals with knee osteoarthritis (KOA). Pharmacological interventions are normally used to treat both hypertension and KOA; however, a more sustainable form of treatment is desirable for these clinical conditions. Whole-body vibration (WBV) exercise has been proposed as a non-pharmacological therapy for reducing both BP and KOA symptomatology. This study aimed to evaluate the antihypertensive effect of WBV in hypertensive individuals with KOA. (2) Methods: Nineteen hypertensive individuals with KOA were randomly allocated to either a control (CG) (n = 9) or a WBV group (WBVG) (n = 10). Subjects in the WBVG were positioned sitting in a chair in front of a vibrating platform (VP) with the feet on the base (peak-to-peak displacement 2.5, 5.0 and 7.5 mm; frequencies 5 to 14 Hz). In the CG, subjects assumed the same position with the VP turned off. The protocols in the CG and WBVG were performed 2 days/week for a total of 5 weeks. (3) Results: No baseline differences (age, anthropometrics, BP parameters and medications) between the groups were found (p > 0.05). WBV exercise reduced systolic BP (SBP: 126.1 ± 2.7 versus 119.1 ± 3.2 mmHg; p = 0.001; post hoc: p = 0.02; F = 23.97) and mean BP (MBP: 82.6 ± 1.8 versus 78.7 ± 1.8, p = 0.001, post hoc: p = 0.02; F = 23.97), while no significant changes were found in diastolic BP (DBP: 68.5 ± 2.2 versus 64.4 ± 2.3; p = 0.11; F = 2.68). (4) Conclusions: WBV might be considered a sustainable therapy for exerting an antihypertensive effect in medicated hypertensive individuals with KOA. This decline in BP might translate to a reduction in pharmacological need, although further studies are necessary to understand the mechanisms underlying the described effect.
KW - Hypertension
KW - Knee osteoarthritis
KW - Non-pharmacological treatment
KW - Physical and rehabilitation medicine
KW - Sustainability
KW - Whole-body vibration
UR - http://www.scopus.com/inward/record.url?scp=85094598767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094598767&partnerID=8YFLogxK
U2 - 10.3390/su12218944
DO - 10.3390/su12218944
M3 - Article
AN - SCOPUS:85094598767
VL - 12
SP - 1
EP - 13
JO - Sustainability
JF - Sustainability
SN - 2071-1050
IS - 21
M1 - 8944
ER -